Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M.L. Brance is active.

Publication


Featured researches published by M.L. Brance.


British Journal of Nutrition | 2012

Luminal calcium concentration controls intestinal calcium absorption by modification of intestinal alkaline phosphatase activity.

L.R. Brun; M.L. Brance; Alfredo Rigalli

Intestinal alkaline phosphatase (IAP) is a brush-border phosphomonoesterase. Its location suggests an involvement in the uptake of nutrients, but its role has not yet been defined. IAP expression parallels that of other proteins involved in Ca absorption under vitamin D stimulation. Experiments carried out in vitro with purified IAP have demonstrated an interaction between Ca and IAP. The gut is prepared to face different levels of Ca intake over time, but high Ca intake in a situation of a low-Ca diet over time would cause excessive entry of Ca into the enterocytes. The presence of a mechanism to block Ca entry and to avoid possible adverse effects is thus predictable. Thus, in the present study, Sprague-Dawley rats were fed with different amounts of Ca in the diet (0.2, 1 and 2 g%), and the percentage of Ca absorption (%Ca) in the presence and absence of L-phenylalanine (Phe) was calculated. The presence of Phe caused a significant increase in %Ca (52.3 (SEM 6.5) % in the presence of Phe v. 31.1 (sem 8.9) % in the absence of Phe, regardless of the amount of Ca intake; paired t test, P = 0.02). When data were analysed with respect to Ca intake, a significant difference was found only in the group with low Ca intake (paired t test, P = 0.03). Additionally, IAP activity increased significantly (ANOVA, P < 0.05) as Ca concentrations increased in the duodenal lumen. The present study provides in vivo evidence that luminal Ca concentration increases the activity of IAP and simultaneously decreases %Ca, acting as a minute-to-minute regulatory mechanism of Ca entry.


Journal of Enzyme Inhibition and Medicinal Chemistry | 2006

Effect of calcium on rat intestinal alkaline phosphatase activity and molecular aggregation

L.R. Brun; M.L. Brance; Alfredo Rigalli; Rodolfo C. Puche

Two fractions of rat intestinal alkaline phosphatase (IAP) were detected by Western blot: 168 ± 6 and 475 ± 45 kDa. The low molecular weight fraction constitutes 43% of the isolated proteins exhibiting 82% of the enzymatic activity, and a heavier fraction constitutes 57% of the isolated proteins and has 18% of the enzymatic activity. Calcium produced an increase of the 475-kDa form to the detriment of the 168-kDa form. This work also describes the kinetic and structural changes of IAP as a function of calcium concentration. With [Ca2+] < 10 mmole/L, the Ca2+-IAP interaction fitted a binding model with 7.8 ± 4.4 moles of Ca2+ /mole of protein, affinity constant = 19.1 ± 8.4 L/mmole, and enzymatic activity increased as a linear function of [Ca2+] (r = 0.946 p < 0.01). On the other hand, with [Ca2+] >10 mmole/L the data did not fit this model and, the enzymatic activity decreased as a function of [Ca2+] (r = − 0.703 p < 0.05).


Journal of Bone and Mineral Metabolism | 2015

Methodology developed for the simultaneous measurement of bone formation and bone resorption in rats based on the pharmacokinetics of fluoride

Maela Lupo; M.L. Brance; Brenda Lorena Fina; L.R. Brun; Alfredo Rigalli

This paper describes a novel methodology for the simultaneous estimation of bone formation (BF) and resorption (BR) in rats using fluoride as a nonradioactive bone-seeker ion. The pharmacokinetics of flouride have been extensively studied in rats; its constants have all been characterized. This knowledge was the cornerstone for the underlying mathematical model that we used to measure bone fluoride uptake and elimination rate after a dose of fluoride. Bone resorption and formation were estimated by bone fluoride uptake and elimination rate, respectively. ROC analysis showed that sensitivity, specificity and area under the ROC curve were not different from deoxypiridinoline and bone alkaline phosphatase, well-known bone markers. Sprague–Dawley rats with modified bone remodelling (ovariectomy, hyper, and hypocalcic diet, antiresorptive treatment) were used to validate the values obtained with this methodology. The results of BF and BR obtained with this technique were as expected for each biological model. Although the method should be performed under general anesthesia, it has several advantages: simultaneous measurement of BR and BF, low cost, and the use of compounds with no expiration date.


Rheumatology International | 2015

Vitamin D levels and bone mass in rheumatoid arthritis

M.L. Brance; L.R. Brun; Susana Lioi; Ariel Sánchez; Marcelo Abdala; B. Oliveri


SpringerPlus | 2014

Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment

L.R. Brun; A.M. Galich; Eduardo Vega; Helena Salerni; Laura Maffei; Valeria Premrou; Pablo Costanzo; Marcelo Sarli; Paula Rey; María Silvia Larroudé; María Susana Moggia; M.L. Brance; Ariel Sánchez; Grupo Argentino de Estudio del Ranelato de Estroncio


Bone | 2017

Código: 19Vitamin D, bone mineral density and vertebral fractures in type 2 diabetes

M.L. Brance; Luis Agustín Ramírez Stieben; Raquel Dobry; Lilian Anca; Adrián González; María Isabel López; Salvador Bayo; Ariel Sánchez; L.R. Brun


Bone | 2016

Dose of vitamin D required to reach 25-hydroxyvitamin D optimum levels

M.L. Brance; C. Barbosa; L. Dappen; J. Borquez; L.R. Brun


Bone | 2016

Effect of Denosumab on bone mineral density and markers of bone turnover

Ariel Sánchez; L.R. Brun; H. Salerni; P. Costanzo; M.B. Zanchetta; V. Farías; Laura Maffei; V. Premrou; M.S. Larroudé; M.A. Sarli; P. Rey; M.L. Brance; M.M. Pavlove; S. Karlsbrum


Bone | 2016

Densitometric response in postmenopausal osteoporosis treated with strontium ranelate or denosumab

Ariel Sánchez; L.R. Brun; H. Salerni; P. Costanzo; Laura Maffei; V. Premrou; M.A. Sarli; P. Rey; M.S. Larroudé; M.L. Brance; A.M. Galich; E. Vega; M.B. Zanchetta; V. Farías; M.S. Moggia; M.M. Pavlove; S. Karlsbrum


Bone | 2015

Effect of strontium ranelate on bone mass. Follow-up to 3 years

L.R. Brun; A.M. Galich; Laura Maffei; V. Premrou; E. Vega; H. Salerni; M.A. Sarli; P. Costanzo; P. Rey; M.S. Larroudé; M.S. Moggia; M.L. Brance; Ariel Sánchez

Collaboration


Dive into the M.L. Brance's collaboration.

Top Co-Authors

Avatar

L.R. Brun

Facultad de Ciencias Médicas

View shared research outputs
Top Co-Authors

Avatar

Alfredo Rigalli

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

Laura Maffei

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

A.M. Galich

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Maela Lupo

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

A Traverso

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

B. Oliveri

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

Rodolfo C. Puche

Facultad de Ciencias Médicas

View shared research outputs
Top Co-Authors

Avatar

Brenda Lorena Fina

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

H. Moreno

Facultad de Ciencias Médicas

View shared research outputs
Researchain Logo
Decentralizing Knowledge